Comment on Pivotal third year coming up for Eagles' Cox

Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks Yahoo FinanceLilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution | Eli Lilly and Company Investors | Eli Lilly and CompanyAmid duel with Novo's Wegovy, Lilly's Zepbound homes in on potential FDA sleep apnea nod FiercePharmaWeight-Loss Drug Zepbound Offers a New Way to Treat Sleep Apnea The New York Times

NASA calls off spacewalk at last minute as astronaut suit malfunctions CNNView Full Coverage on Google News

A ketamine pill may help hard-to-treat depression with fewer side effects, early research suggests CNNExtended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial Nature.comSlow-release ketamine tablets help prevent depression relapses, UK trial finds The GuardianElon Musk-backed ketamine therapy offers hope to patients with severe depression where other medication fails Daily MailKetamine tablets help reduce side-effects in depression sufferers Financial Times

Young gay Latinos see a rising share of new HIV cases, leading to a call for targeted funding The Associated PressView Full Coverage on Google News

NASA-Falcon Heavy launch in Florida: Best views from Treasure Coast TCPalmSpaceX Falcon Heavy launch: Where to watch mammoth rocket liftoff in Daytona, New Smyrna Beach Daytona Beach News-JournalWhen is next rocket launch from Florida? Mammoth SpaceX Falcon Heavy Florida TodayHow the GOES U satellite will change Earth and space weather forecasts forever Space.comNASA Invites Public to Share Excitement of NOAA GOES-U Launch NASA

Former director of the CDC predicts the next pandemic will be from bird flu The IndependentOpinion | How Scared Should You Be of Bird Flu? The New York TimesBird flu threat is low in CT, but experts are monitoring spread The Connecticut MirrorGlobal failure to prepare for pandemics ‘gambling with children’s future’ The Guardian